Equitable Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,227
| Closed | -$201K | – | 1134 |
|
|
2023
Q3 | $201K | Buy |
7,227
+573
| +9% | +$16K | ﹤0.01% | 1008 |
|
|
2023
Q2 | $227K | Buy |
+6,654
| New | +$227K | ﹤0.01% | 950 |
|
|
2022
Q4 | – | Sell |
-12,250
| Closed | -$403K | – | 900 |
|
|
2022
Q3 | $403K | Sell |
12,250
-1,756
| -13% | -$57.8K | 0.01% | 614 |
|
|
2022
Q2 | $441K | Buy |
14,006
+3,280
| +31% | +$103K | 0.01% | 588 |
|
|
2022
Q1 | $493K | Sell |
10,726
-2,758
| -20% | -$127K | 0.01% | 578 |
|
|
2021
Q4 | $826K | Sell |
13,484
-3,942
| -23% | -$241K | 0.01% | 442 |
|
|
2021
Q3 | $1.3M | Buy |
17,426
+2,181
| +14% | +$163K | 0.02% | 329 |
|
|
2021
Q2 | $1.41M | Buy |
15,245
+981
| +7% | +$90.7K | 0.02% | 311 |
|
|
2021
Q1 | $1.27M | Buy |
14,264
+2,324
| +19% | +$206K | 0.03% | 316 |
|
|
2020
Q4 | $1.11M | Sell |
11,940
-280
| -2% | -$26.1K | 0.03% | 304 |
|
|
2020
Q3 | $779K | Buy |
12,220
+6,649
| +119% | +$424K | 0.02% | 337 |
|
|
2020
Q2 | $291K | Buy |
+5,571
| New | +$291K | 0.01% | 511 |
|